AGATHER ONYANGO: Open Payments
NPI 1194367813 · GRAND PRAIRIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 23 payments from 10 companies in 2025. Trend: 2023 $282 · 2024 $322 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $262 |
| ABBVIE INC. | 5 | $80 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: ABILIFY MAINTENA, VRAYLAR, UZEDY, COBENFY, INGREZZA, FANAPT, INVEGA SUSTENNA, LYBALVI.
Industry payments across TX — which companies pay providers there.
